Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
Mateus M. Bergamaschi(Universidade de São Paulo), José Alexandre S. Crippa(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Rocío Martín‐Santos(Centro de Investigación Biomédica en Red de Salud Mental), Rafael Roesler(Universidade Federal do Rio Grande do Sul), Nadja Schröder(Ruhrlandklinik), Regina Helena Costa Queiróz(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Antônio Egídio Nardi(Brazilian Academy of Sciences), Marcos Hortes Nisihara Chagas(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Danielle Chaves Gomes de Oliveira(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Antônio Waldo Zuardi(Universidade de Ribeirão Preto), João Quevedo(The University of Texas Health Science Center), Jaime E. C. Hallak(Universidade de Ribeirão Preto), Flávio Kapczinski(Universidade Federal do Rio Grande do Sul), Bruno Spinosa De Martinis(Conselho Nacional de Desenvolvimento Científico e Tecnológico)
Cited by 763
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
|Bipolar Disorders|2009|569
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530